Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits. - Peelaerts W; Bergkvist L; George S; Johnson M; Meyerdirk L; Schulz E; Steiner JA; Madaj Z; Ma J; Becker K; Nilsson KPR; Colca JR; et al. (Free neuropathology, 2020)